Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Saturday, July 05, 2014 9:44:38 AM
bullish
$ORMP
DD Notes ~ http://www.ddnotesmaker.com/ORMP
##### recent news/filings ~ source: finance.yahoo.com
Mon, 23 Jun 2014 12:15:00 GMT ~ Oramed Pharmaceuticals to Present at the BIO International Convention in San Diego
[PR Newswire] - Oramed Pharmaceuticals Inc. (ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that its Chief Executive Officer, Nadav Kidron, will present at the 2014 BIO International Convention. This year's global event for biotechnology will take place on June 23-26 at the San Diego Convention Center in San Diego, California. The BIO International Convention, the largest global event for the biotechnology industry, will highlight the latest trends and the newest opportunities for executives, investors, scientists, policy leaders, and media from around the world.
read full: http://finance.yahoo.com/news/oramed-pharmaceuticals-present-bio-international-121500133.html
*********************************************************
Tue, 10 Jun 2014 12:15:00 GMT ~ Oramed Pharmaceuticals to Present at the American Diabetes Association 74th Scientific Sessions on June 13 - 17, 2014 in San Francisco
[PR Newswire] - Oramed Pharmaceuticals Inc. (ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that three scientific abstracts summarizing studies performed with ORMD-0801, its orally ingestible insulin capsule, were accepted for inclusion at the American Diabetes Association 74th Scientific Sessions, which will take place in San Francisco. Two abstracts will be presented at poster sessions and all three will be published in the Scientific Sessions Abstract Book. The posters will be attended by Oramed's Chief Scientific Officer, Dr. Miriam Kidron.
read full: http://finance.yahoo.com/news/oramed-pharmaceuticals-present-american-diabetes-121500034.html
*********************************************************
Tue, 03 Jun 2014 22:32:09 GMT ~ The Importance Of Being Oral
read full: http://seekingalpha.com/article/2251533-the-importance-of-being-oral?source=yahoo
*********************************************************
Thu, 29 May 2014 16:00:00 GMT ~ Oramed Pharmaceuticals Added to the Morgan Stanley Capital International (MSCI) MicroCap Index
[PR Newswire] - Oramed Pharmaceuticals Inc. (ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has been added to the Morgan Stanley Capital International (MSCI) MicroCap Index, effective as of market close on May 30, 2014. MSCI is a leading provider of investment decision support tools to over 6,000 clients worldwide, ranging from pension plans to boutique hedge funds. The MSCI MicroCap Indexes are one of several key indexes and cover approximately 5,000 microcap securities across developed markets countries. Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection.
read full: http://finance.yahoo.com/news/oramed-pharmaceuticals-added-morgan-stanley-160000005.html
*********************************************************
Thu, 29 May 2014 11:55:40 GMT ~ Barclays to hold a conference
read full: http://www.theflyonthewall.com/permalinks/entry.php/BLRX;EVGN;GLMD;ORMP;PSTI;ELOSid2017396/BLRX;EVGN;GLMD;ORMP;PSTI;ELOS-Barclays-to-hold-a-conference
*********************************************************
##### chart ~ source: stockcharts.com
##### chart ~ source: eoddata.com
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ORMP/company-info
Ticker: $ORMP
OTC Market Place: Not Available
CIK code: 0001176309
Company name: Oramed Pharmaceuticals, Inc.
Company website: http://www.oramed.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001176309&owner=exclude&count=40
Latest filings: http://www.otcmarkets.com/stock/ORMP/filings
Latest financials: http://www.otcmarkets.com/stock/ORMP/financials
Latest news: http://www.otcmarkets.com/stock/ORMP/news - http://finance.yahoo.com/q/h?s=ORMP+Headlines
Major holdings: http://data.cnbc.com/quotes/ORMP/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=ORMP+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/ORMP.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=ORMP
RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=ORMP&search=search
DTCC: http://search2.dtcc.com/?q=Oramed+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Oramed+Pharmaceuticals%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Oramed+Pharmaceuticals%2C+Inc.&x=0&y=0
WHOIS: http://whois.domaintools.com/http://www.oramed.com
Alexa: http://www.alexa.com/siteinfo/http://www.oramed.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.oramed.com
Short Sales: http://www.otcmarkets.com/stock/ORMP/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/ORMP/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/ORMP/research
Historical Prices: http://finance.yahoo.com/q/hp?s=ORMP+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=ORMP+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=ORMP+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=ORMP+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=ORMP+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=ORMP+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=ORMP
Balance Sheet: http://finance.yahoo.com/q/bs?s=ORMP
Cash Flow: http://finance.yahoo.com/q/cf?s=ORMP+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/ORMP
Bloomberg: http://www.bloomberg.com/quote/ORMP:US
Morningstar: http://quotes.morningstar.com/stock/s?t=ORMP
Bussinessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ORMP
Barchart: http://www.barchart.com/quotes/stocks/ORMP
OTC Short Report: http://otcshortreport.com/index.php?index=ORMP
Investopedia: http://www.investopedia.com/markets/stocks/ORMP/?wa=0
http://www.pennystocktweets.com/stocks/profile/ORMP
##### last known share structure ~ source: otcmarkets.com
Market Value: $95,647,706 a/o Jul 03, 2014
Shares Outstanding: 9,942,589 a/o Apr 08, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
##### business description ~ source: otcmarkets.com
Oramed Pharmaceuticals (OTC:ORMP.OB) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an oral insulin capsule currently in Phase 2 trials, the Company is seeking to revolutionize the treatment of diabetes.
DD Notes ~ http://www.ddnotesmaker.com/ORMP
cnds
Recent ORMP News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 12:06:24 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/16/2024 08:42:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 08:05:24 PM
- Oramed Letter to Shareholders • PR Newswire (US) • 06/26/2024 01:05:00 PM
- Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock • PR Newswire (US) • 06/26/2024 01:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 06/20/2024 11:32:05 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/20/2024 11:30:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 09:28:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 09:15:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:00:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 01:00:27 PM
- Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation • GlobeNewswire Inc. • 03/19/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/06/2024 10:00:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 01:42:26 PM
- Oramed Letter to Shareholders • PR Newswire (US) • 02/20/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 10:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:45:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:45:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:43:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:41:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:40:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:39:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:37:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:36:18 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM